Nexien Biopharma Inc
OTC:NXEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nexien Biopharma Inc
OTC:NXEN
|
US |
Nexien Biopharma Inc
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company is headquartered in Glendale, Colorado. The company went IPO on 2001-07-11. The firm is engaged in the development of drugs containing cannabinoids for the treatment of various diseases, disorders and medical conditions, and owns a license covering certain intellectual property, including certain patent applications. The Company’s subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company is headquartered in Glendale, Colorado. The company went IPO on 2001-07-11. The firm is engaged in the development of drugs containing cannabinoids for the treatment of various diseases, disorders and medical conditions, and owns a license covering certain intellectual property, including certain patent applications. The Company’s subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.
